Skip to main content
OpenTrials

Clinical trial condition

COVID-19

Explore clinical trials studying COVID-19. Study availability and eligibility vary by location and protocol.

4,623 public trials 207 recruiting studies
Refine in advanced search Browse all conditions

COVID-19 trial results

Completed

Enhanced Triage for COVID-19

NCT04750369

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Pontifícia Universidade Católica do Rio Grande do Sul Porto Alegre, Brazil
  • University Health Network Toronto, Ontario, Canada
  • Cittá della Salute e della Scienza di Torino Hospital-Molinette Site Turin, Italy
View Trial Details
Completed

LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780268

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue Tucson, Arizona, United States
  • Community Regional Medical Center (Site 203-005), 2823 Fresno Street Fresno, California, United States
  • Keck Hospital of USC (Site 301-020), 1500 San Pablo Street Los Angeles, California, United States
  • UCSF Medical Center at Mount Zion (Site 203-007), 1600 Divisadero St. San Francisco, California, United States
View all 57 locations
View Trial Details
Completed

VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780281

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue Tucson, Arizona, United States
  • Southern Arizona VA Healthcare System (Site 074-009), 3601 S. 6th Ave. Tucson, Arizona, United States
  • Community Regional Medical Center (Site 203-005), 2823 Fresno Street Fresno, California, United States
  • VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street Loma Linda, California, United States
View all 105 locations
View Trial Details
Completed

Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

NCT05172050

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • CHU Amiens Amiens, France
  • Clinique de l'infirmerie protestante de Lyon Caluire-et-Cuire, France
  • CH Emile Roux le Puy en Velay Le Puy-en-Velay, France
  • Centre Hospitalier de Troyes Troyes, France
View Trial Details
Completed

Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection

NCT04818216

Conditions
Acute Kidney Injury, COVID-19, Coronaviridae Infections, +18 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
  • The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
  • University Health Systems San Antonio, Texas, United States
  • Harborview Medical Center Seattle, Washington, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

NCT04611802

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Alabama Clinical Therapeutics, Llc (Pediatric Site) Birmingham, Alabama, United States
  • Accel Research Sites (Adult Site) Birmingham, Alabama, United States
  • Central Research Associates, Inc (Pediatric Site) Birmingham, Alabama, United States
  • The Pain Center of Arizona (Adult Site) Phoenix, Arizona, United States
View all 154 locations
View Trial Details

Related conditions